Evidence map›Paper›PMID 41122298›Full record

ArticleHealth information science and systems2025

Evaluating topological and graph-theoretical approaches to extract complex multimodal brain connectivity patterns in multiple sclerosis.

Toni Lozano-Bagén, Eloy Martinez-Heras, Giuseppe Pontillo, Elisabeth Solana, Francesc Vivó, Maria Petracca, Alberto Calvi, Sandra Garrido-Romero, Albert Solé-Ribalta, Sara Llufriu and 2 more

Abstract read
In one paragraph

Article in Health information science and systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Toni Lozano-BagénDepartment of Computer Science, Universitat Autònoma de Barcelona, Barcelona, Spain.
Eloy Martinez-HerasNeuroimmunology and Multiple Sclerosis Unit, Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clínic de Barcelona, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Giuseppe PontilloFaculty of Brain Sciences, Department of Neuroinflammation, Queen Square MS Centre, UCL Institute of Neurology, University College London, London, United Kingdom.
Elisabeth SolanaNeuroimmunology and Multiple Sclerosis Unit, Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clínic de Barcelona, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Francesc VivóNeuroimmunology and Multiple Sclerosis Unit, Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clínic de Barcelona, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Maria PetraccaDepartment of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples "Federico II", Naples, Italy.
Alberto CalviNeuroimmunology and Multiple Sclerosis Unit, Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clínic de Barcelona, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Sandra Garrido-Romeroe-Health Center, Universitat Oberta de Catalunya, Barcelona, Spain.
Albert Solé-RibaltaInternet Interdisciplinary Institute (IN3), Universitat Oberta de Catalunya, Barcelona, Spain.
Sara LlufriuNeuroimmunology and Multiple Sclerosis Unit, Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clínic de Barcelona, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Ferran PradosFaculty of Brain Sciences, Department of Neuroinflammation, Queen Square MS Centre, UCL Institute of Neurology, University College London, London, United Kingdom.
Jordi Casas-RomaDepartment of Computer Science, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-0617-3303

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain networks, or graphs, derived from magnetic resonance imaging (MRI) offer a powerful framework for representing the structural, morphological, and functional organization of the brain. Graph-theoretical metrics have been widely employed to characterize properties such as efficiency, integration, and communication within these networks. More recently, topological data analysis techniques, such as persistent homology and Betti curves, have emerged as complementary approaches for capturing higher-order network patterns. In this study, we present a comparative analysis of these feature-generation methodologies in the context of neurodegenerative disease. Specifically, we evaluate the effectiveness of Betti curves and graph-theoretical metrics in extracting features for distinguishing people with multiple sclerosis (PwMS) from healthy volunteers (HV). Features are derived from structural connectivity, morphological gray matter, and resting-state functional networks, using both single layer and multilayer graph architectures. Our experiments, conducted on a cohort of PwMS and HV, demonstrate that features extracted using Betti curves generally outperform those based on graph-theoretical metrics. Furthermore, we show that multimodal data in terms of feature concatenation and multilayer graph architectures provide a more comprehensive representation of alterations in complex brain mechanisms associated with MS, leading to improved classification performance. These findings highlight the potential of topological features and multimodal integration for enhancing the understanding and diagnosis of neurodegenerative disorders.

Indexed as

Brain networksGraph theoryMachine learningMRIMultiple sclerosisPersistent homology

Identifiers

PMID41122298
PMCPMC12535957

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.